This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H12N5 Hemagglutinin (HA), N-His
Product Overview
BioVenic's Recombinant Influenza A H12N5 Hemagglutinin (HA), N-His is a recombinant protein expressed from E.coli Expression System. Its predicted molecular weight is 29.3 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
Hemagglutinin (HA) is the primary envelope glycoprotein of the Influenza A virus (H12N5), essential for viral infectivity. It functions as a Class I fusion protein that mediates viral attachment by binding to host cell surface receptors containing alpha 2,3-linked sialic acids, typical of avian species. Following endocytosis, HA undergoes a low-pH-triggered conformational change to facilitate membrane fusion. As the dominant surface antigen, H12 HA is a key target for neutralizing antibodies and serves as a critical component in avian influenza surveillance and vaccine research.
Shipping and Storage
This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.